Qiagen N.V.
QGEN
NYSE·Healthcare·Medical - Diagnostics & Research·Mkt cap $9.0B
$43.47
▼ -0.89%
P/E
22.29
Mkt Cap
$9.0B
52-Wk Range
$32.53–$57.82
52-Week Range
$32.53 - $57.82
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 8.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Value
Fairly valued vs sector peers
Momentum
Strong
+20.0% over 3m
Quality
Excellent
Strong fundamentals
Dividend
High yield
6.07% yield
Smart-money signal
Who's buying QGEN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 5, 2026
Reported EPS of $0.62 vs $0.60 consensus (+3.7% surprise). Revenue of $535.0M vs $527.5M expected (+1.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+3.7%
Revenue trend · last 8Q
—
—
—
—
+6%
+4%
+2%
+0%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$501.9M
$521.2M
$483.5M
$533.5M
$532.6M
$540.4M
$492.3M
$535.0M
Margins · last 8Q
Profit
19.3%
Wall Street consensus
8 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 10, 2026
vs Industry
How QGEN stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.